BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 263 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $42,000 | -2.3% | 388 | -6.3% | 0.00% | – |
| Q3 2021 | $43,000 | -98.9% | 414 | -99.1% | 0.00% | -100.0% |
| Q2 2021 | $3,893,000 | -46.8% | 44,257 | -41.2% | 0.01% | -50.0% |
| Q1 2021 | $7,312,000 | -44.0% | 75,207 | -35.4% | 0.01% | -48.1% |
| Q4 2020 | $13,063,000 | +1475.8% | 116,474 | +1202.8% | 0.03% | +1250.0% |
| Q3 2020 | $829,000 | +82800.0% | 8,940 | +148900.0% | 0.00% | – |
| Q3 2019 | $1,000 | -100.0% | 6 | -100.0% | 0.00% | -100.0% |
| Q2 2019 | $13,466,000 | +96.0% | 142,754 | +90.5% | 0.03% | +65.0% |
| Q1 2018 | $6,871,000 | +317.4% | 74,933 | +130.7% | 0.02% | +300.0% |
| Q2 2017 | $1,646,000 | +72.4% | 32,487 | +36.0% | 0.01% | +66.7% |
| Q1 2017 | $955,000 | +42.5% | 23,880 | 0.0% | 0.00% | +50.0% |
| Q4 2016 | $670,000 | +17.1% | 23,880 | +24.0% | 0.00% | 0.0% |
| Q3 2016 | $572,000 | – | 19,262 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |